Clinical chemistry in women treated with levonorgestrel implants (NORPLANT™∗∗NORPLANT™is the Population Council's trademark for subdermal implants containing levonorgestrel.) or a TCu 200 IUD
- 1 March 1983
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 27 (3) , 281-288
- https://doi.org/10.1016/0010-7824(83)90006-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A five-year clinical trial of levonorgestrel silastic implants (Norplant™)Contraception, 1982
- A three-year clinical trial with levonorgestrel silastic implantsContraception, 1979
- Clinical chemistry in women treated with progestogen implantsContraception, 1978
- The effects of norgestrel on carbohydrate and lipid metabolism over one yearAmerican Journal of Obstetrics and Gynecology, 1976
- Sex Hormone Binding Globulin : The Carrier Protein For d-NorgestrelJournal of Clinical Endocrinology & Metabolism, 1976
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976
- The Effect of D-Norgestrel, 30 Micrograms, on The Oral Glucose Tolerance Test, Including Insulin Levels, in Thai WomenFertility and Sterility, 1976
- The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacityContraception, 1975
- EFFECTS OF LONG-TERM MICRODOSAGE OF NORGESTREL ON GLUCOSE TOLERANCE AND SERUM TRANSAMINASE LEVELSReproduction, 1970
- Oral Glucose Tolerance and Related Factors in a Normal Population Sample--I. Blood Sugar, Plasma Insulin, Glyceride, and Cholesterol Measurements and the Effects of Age and SexBMJ, 1969